Consulting capabilities
Each engagement is built around a specific decision — combining proprietary research infrastructure, quantitative modelling, sector expertise and direct analyst support.
We work across the commercial decision lifecycle — from sizing an opportunity to entering a market, defending a portfolio and closing a deal. Explore the core capabilities below, then tell us the decision you're facing.
Market Opportunity & Forecasting
TAM/SAM/SOM sizing, segmentation, country-level opportunity assessment, demand forecasting and scenario modelling — so you can size a market and defend the number to a board.
Growth & Market-Entry Strategy
Market prioritization, entry-mode assessment, customer and channel strategy, pricing and positioning, and commercialization roadmaps for new markets and new products.
Competitive & Customer Intelligence
Competitor benchmarking, product and pipeline tracking, voice-of-customer research and KOL/stakeholder mapping — a continuously refreshed view of the field you compete in.
Portfolio & Asset Strategy
Asset prioritization, indication assessment, pipeline and whitespace analysis and portfolio scenario planning to focus investment on the assets that matter.
Commercial Due Diligence & Partner Scouting
Market-attractiveness and acquisition-target assessment, partner and licensing searches, and CDMO/CRO/vendor shortlisting to support deals and diligence.
Pricing, Reimbursement & Market Access
Pricing strategy, payer-landscape and reimbursement mapping, HTA evidence review, value-dossier support and access strategy across key geographies.
Epidemiology & Patient-Based Forecasting
Patient-pool analysis, epidemiology-driven outlooks, treatment-flow mapping and indication prioritization to ground forecasts in the patient reality.
Custom Intelligence Platforms
Bespoke dashboards and models — including our Animal Health and Pharmaceutical CDMO market-intelligence dashboards, Excel pivot models, Power BI dashboards and competitor-monitoring platforms.